Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPOSE: PASCs in Parkinson's Disease
NCT06141317Phase 2Completed
- Sponsor
- ClusterXStem
- Start
- Jun 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 2, randomised trial in Parkinson's disease (PD) (2 arms), sponsored by ClusterXStem. Primary endpoints: Unified Parkinson's Disease Rating Scale Total Score at 12 months, 39-item Parkinson's disease Questionnaire at 12 months and 8 more. Started Jun 2023; status: completed.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06141317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06141317.